MCK Q4 2023 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q4 2023 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$68.9B+4.2% YoY

Gross Profit

$3.0B4.3% margin

Operating Income

$1.1B1.6% margin

Net Income

$787M1.1% margin

EPS (Diluted)

$5.70

QoQ Revenue Growth

-2.2%

Cash Flow

Operating Cash Flow

$3.3B

Free Cash Flow

$3.1B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$62.3B

Total Liabilities

$63.8B

Stockholders' Equity

-$1.9B

Cash & Equivalents

$4.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68.9B	$66.1B	+4.2%
Gross Profit	$3.0B	$3.2B	-7.8%
Operating Income	$1.1B	$787M	+40.0%
Net Income	$787M	$368M	+113.9%

Revenue Segments

U.S. Pharmaceutical Segment

$61.7B90%

International Segment

$3.4B5%

Medical-Surgical Solutions Segment

$2.7B4%

Prescription Technology Solutions

$1.2B2%